PM1003

· Biotheus Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PM1003, covering 2023-05-17 to 2023-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors [Phase 1, Phase 2]